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Previous studies have documented that, in the presence of the mutagenic base analogue
5-fluorouracil (FU), lymphocytic choriomeningitis virus (LCMV) that persisted in BHK-21 cells
decreased its infectivity to a larger extent than intracellular viral RNA levels, prior to virus
extinction. This observation, together with in silico simulations, led to the proposal of the lethal
defection model of virus extinction. This model suggests the participation of defective-interfering
genomes in the loss of infectivity by increased mutagenesis. Since LCMV naturally produces
defective-interfering particles, it was important to show that a capacity to interfere is produced in
association with FU treatment. Here, we document that BHK-21 cells persistently infected with
LCMV grown in the presence of FU, but not in its absence, generated an interfering activity that
suppressed LCMV infectivity. Interference was specific for LCMV and was sensitive to UV
irradiation and its activity was dose- and time-dependent. The interfering preparations produced
positive LCMV immunofluorescence and viral particles seen by electron microscopy when used to
infect cells, despite some preparations being devoid of detectable infectivity. Interference did not
involve significant increases of mutant spectrum complexity, as predicted by the lethal defection
model. The results provide support for a specific interference associated with LCMV when the
virus replicates in the presence of FU. The excess of interference relative to that observed in the
absence of FU is necessary for LCMV extinction.
INTRODUCTION
As a consequence of the low fidelity of viral RNA-dependent
RNA and DNA polymerases, virus replication within a host
generates mutant spectra consisting of dynamic distributions
of viral genomes in competition that are ranked according to
their relative fitness. They have been termed virus quasi-
species by analogy with the concept of molecular quasispe-
cies, developed by Eigen and Schuster as a theory of
molecular evolution of primitive replicons (Eigen, 1971;
Eigen et al., 1988; Eigen & Schuster, 1979). Viral quasispecies
are endowed with great adaptability, and both the composi-
tion of the mutant spectrum and interactions among its
components may influence the evolutionary dynamics of the
virus (reviewed by Domingo, 2006; Domingo et al., 2008a, b).
A manifestation of adaptability is the selection of drug-
resistant mutants that may contribute to treatment failures
(Coffin, 1995; Na´jera et al., 1995; Nijhuis et al., 2009). There
is a need to develop new antiviral strategies for variable
viruses that prevent or minimize selection of drug-resistant
viral mutants. One such strategy, termed lethal mutagenesis,
is based on the theoretical concept of entry into error
catastrophe (Eigen, 1971; Eigen et al., 1988; Eigen & Schuster,
1979). According to this concept, for any replicating entity,
there is an upper value of the mutation rate, termed the error
threshold, which must not be crossed if the wild-type genome
distribution is to be kept stable (Biebricher & Eigen, 2005;
Eigen, 2002). Applied to viruses, an increase of the mutation
rate above some critical valuemight lead to drift of sequences,
disorganization of the quasispecies and, consequently, to loss
of infectivity (Eigen, 2002). This hypothesis has been amply
supported experimentally (Crotty et al., 2001; Grande-Pe´rez
et al., 2002; Holland et al., 1990; Martin & Domingo, 2008;
Martin et al., 2008; Pariente et al., 2001, 2003; Ruiz-Jarabo
et al., 2003; Sierra et al., 2000; reviewed by Anderson et al.,
2004; Domingo, 2005; Graci & Cameron, 2004).
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The mutant spectrum can influence the behaviour of indi-
vidual viral variants, and can suppress variants of superior
fitness as well as virulent, drug-resistant or pathogenic
variants present at low frequency in the population
(Crowder & Kirkegaard, 2005; Chumakov et al., 1991; de
la Torre & Holland, 1990; Gonza´lez-Lo´pez et al., 2004;
Teng et al., 1996). In agreement with the suppressive effects
of mutant spectra, the transition to extinction of
lymphocytic choriomeningitis virus (LCMV) during per-
sistent infections in cell culture subjected to mutagenesis by
5-fluorouracil (FU) was characterized by a progressive
decrease in virus infectivity that was more pronounced
than the decrease of viral RNA levels (Grande-Pe´rez et al.,
2005b). These observations, together with in silico simula-
tions of RNA genome replication under mutagenesis, led to
the proposal of the lethal defection model of viral
extinction, which has been supported by additional
theoretical studies (Iranzo & Manrubia, 2009). According
to this model, as a result of modest increases in the
mutation rate, lethality is limited, but the mutant spectrum
is enriched with defector RNA genomes that perturb viral
functions and mediate decreases of infectivity and
extinction (Grande-Pe´rez et al., 2005a). Parallel studies
carried out with the picornavirus foot-and-mouth disease
virus (FMDV) have provided independent evidence for the
suppressive effects of mutant spectra (Gonza´lez-Lo´pez et
al., 2004). In particular, well-characterized capsid and
polymerase mutants of FMDV exerted a specific interfer-
ence on FMDV RNA replication, and contributed to
extinction (Perales et al., 2007, 2009).
Arenaviruses are attractive pathogens to investigate the
mechanisms and possible application of lethal mutagenesis
because of the very limited number of effective antiviral
inhibitors available and the impact of arenavirus diseases
on human health (Buchmeier et al., 2007; Macher & Wolfe,
2006; Peters, 2002). Administration of FU to mice impeded
the establishment of a persistent infection with LCMV, an
observation that constituted a proof-of-principle of the
feasibility of a lethal mutagenesis approach in vivo (Ruiz-
Jarabo et al., 2003). LCMV is the prototype arenavirus; its
genome includes two RNA segments, L and S, that use an
ambisense strategy for gene expression. The L segment
encodes the 90 amino acid Z protein, a zinc-finger protein
implicated in budding (Pe´rez et al., 2003; Salvato et al.,
1992), and the L protein, the RNA-dependent RNA
polymerase, of 2210 amino acids (Fuller-Pace &
Southern, 1989; Lee et al., 2000; Lopez et al., 2001; Singh
et al., 1987). The S segment encodes the glycoprotein
precursor (GP-C) and the nucleoprotein (NP) (Buchmeier
et al., 2007).
In the present study, we have used LCMV to demonstrate
that virus extinction by enhanced mutagenesis is achieved
through the specific interference generated during LCMV
replication in the presence of a mutagenic agent. The
interference required FU mutagenesis, since it was not
observed in infected cultures maintained under the same
conditions but in the absence of FU. Under basal mutation
rates, the accumulation of interfering activity was insuf-
ficient to achieve LCMV extinction. The results provide
further support for the lethal defection model of virus
extinction and reinforce the concept that limited mutagen-
esis may suffice to drive a virus towards extinction.
RESULTS
BHK-21 cell cultures persistently infected with
LCMV in the presence of FU accumulate an
interfering component
The previously proposed lethal defection model of LCMV
extinction (Grande-Pe´rez et al., 2005b) has been further
tested by monitoring LCMV infectivity and genomic RNA
levels in the culture medium of BHK-21 cells persistently
infected with LCMV, grown in either the absence or
presence of FU. Infectivity was determined by plaque assay
on Vero cells, in which several rounds of replication and
cell-to-cell propagation of viruses occur (see Methods for
a detailed procedure). Parallel, persistently infected
cultures were maintained either in periodically renewed
medium (Fig. 1a; first design) or in the same culture
medium (Fig. 1b; second design). In the first design, at
fixed time intervals, all the medium on a monolayer was
removed, and fresh medium with FU was added. In the
second design, the medium removed for analysis (300 ml;
6% of the total) was replaced at fixed time intervals by the
equivalent volume from a culture medium of BHK-21
cells grown in parallel in the presence of the same
concentration of FU. The results (Fig. 1a, b) show that,
despite a decrease of infectivity of several logarithms in
the presence of FU, extinction (loss of infectivity) was
only achieved in the cultures in which the medium was
not changed (second design) (Fig. 1b). In this case, the
infected cultures maintained LCMV RNA levels that were
101- to 102-fold higher than in cultures in which the
medium was periodically renewed (Fig. 1c, d). Increased
viral RNA levels relative to infectivity led to statistically
significant decreases of specific infectivity (Fig. 1f). The
difference of specific infectivity between the LCMV
populations produced in the presence and absence of
FU was significant (P,0.05, Student’s t-test; Fig. 1f)
throughout the duration of the infection (Fig. 1b). In
contrast, this difference was not significant when extinc-
tion did not occur (first design) (P50.15, Student’s t-test;
Fig. 1e). The results were similar in duplicate cultures, and
indicate that the interfering activity generated during
persistent LCMV infections, and the ensuing LCMV
extinction, are dependent on the presence of FU and on
another component that accumulates in the culture
medium; FU per se is not sufficient to promote extinction.
The results also suggest that supernatants of infections
carried out in the presence of FU produce a significant
decrease of LCMV infectivity, with a modest decrease of
LCMV RNA levels, in agreement with previous results
(Grande-Pe´rez et al., 2005b).
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Intracellular nucleotide levels
Deprivation of standard ribonucleotides can limit RNA
genome replication, and nucleotide pool imbalances can be
mutagenic (Anglana et al., 2003; Kunz et al., 1994;
Mathews, 2006). The concentration of standard nucleoside
triphosphates was 2- to 19-fold lower in the presence of FU
triphosphate (FUTP), but did not differ significantly
between the persistently infected cell cultures in which
extinction did not occur (first design) and those in which it
occurred (second design) (Fig. 2). Furthermore, intracel-
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Fig. 1. Effect of cell-culture medium on LCMV infectivity during FU-induced mutagenesis. Monolayers with 3106 BHK-21
cells were infected with LCMV ARM-53b at an m.o.i. of 0.01 p.f.u. per cell, in either the presence of FU (100 mg ml”1) (red lines
and symbols; FUA and FUB) or the absence of FU (blue lines and symbols; LCMVA and LCMVB). (a, c, e) At the indicated times
post-infection, the culture medium was removed and replaced by culture medium of BHK-21 cells grown in either the presence
or the absence of FU (design 1). (b, d, f) The culture medium was maintained (except for small aliquots withdrawn for
determination of infectivity and quantification of RNA, which were compensated for by addition of the corresponding medium
from uninfected cultures maintained in parallel) (design 2). Infectivity (a, b) and LCMV RNA levels (c, d) were determined in the
supernatant of the cell cultures in triplicate. Specific infectivity (e, f) was calculated from the infectivity values given in (a) and (b)
and the RNA quantifications given in (c) and (d).
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Fig. 2. Levels of NTPs in persistent infections of LCMV in BHK-21 cells. Values have been normalized to the value for NAD in the same cell extract. (a)
FPLC analysis of NTP levels in cell-culture supernatants, corresponding to the experiment shown in Fig. 1(a) (resistance to extinction) in the absence (”FU)
or presence (+FU) of FU, at the indicated times post-infection. (b) FPLC analysis of NTP levels in cell-culture supernatants, corresponding to the
experiment shown in Fig. 1(b) (viral extinction) in the absence (”FU) or presence (+FU) of FU, at the indicated times post-infection.
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lular FUTP levels were higher in those cultures in which
extinction was not observed. This result argues against an
imbalance of nucleotide pools or a decrease in the FUTP
level as the mechanism of the observed resistance of LCMV
to extinction.
Detection of virus-specific antigens and virus
particles in cells infected with FU-treated viral
populations
In other virus systems, specific interference by viral
mutants required that the interfering genomes be replica-
tion-competent (Crowder & Kirkegaard, 2005; Perales et
al., 2007). To test whether interfering preparations
expressed viral antigens, the supernatants of cultures
persistently infected with LCMV in the presence of FU,
either with or without detectable infectivity [culture media
obtained at 96 h post-infection (p.i.) in the experiment of
Fig. 1a, b] were applied to BHK-21 cell monolayers, using
the standard infection protocol. In all cases, positive NP-
specific immunofluorescence and viral particles were
observed (Fig. 3). Thus, the interfering supernatants
contain replication-competent viral particles.
Stochastic LCMV extinction in BHK-21 cells.
Interference exerted by cell-culture supernatants
displaying different infectivity levels
Previous studies have established that the decrease of
LCMV infectivity prompted by FU treatment occurs
through sharp fluctuations of infectivity that eventually
result in virus extinction (Grande-Pe´rez et al., 2005b). The
stochastic nature (chance occurrence) of the fluctuations
was investigated by determining the infectivity of several
replicate BHK-21 cultures persistently infected with LCMV
in the presence of FU. The results document wide
variations of infectivity among different replicates (3–6),
prior to extinction (Fig. 4a). Two replicates that differed by
about 100-fold in infectivity in the cell-culture super-
natants at 88 h p.i. (asterisks in Fig. 4a) showed minor
differences in interference activity (Fig. 4b), suggesting that
the presence of infectivity is not a requirement for
interference. Similar results were obtained with other
samples (Fig. 4b–d).
Interference is LCMV-specific and UV radiation-
sensitive
Supernatants with interfering activity obtained at 102 h p.i.
(Fig. 1a) were used to perform additional interference
assays, aimed at determining the nature of the interfering
activity. First, interference was consistently exerted on
cultures of BHK-21 cells infected with LCMV, but not on
parallel BHK-21 cultures infected with either encephalo-
myocarditis virus (EMCV) or vesicular stomatitis virus
(VSV) (Fig. 5a). This result rules out induction of
unspecific antiviral components (such as interferon) as
mediators of interference. This is in line with the fact that
BHK-21 cells (like Vero cells) are unable to induce
interferon upon viral infection.
Interference was not due to FU that remained in the
inoculum, since intracellular FUTP was not detected in
cells in which interference occurred or in parallel control
monolayers (Fig. 5b; arrows). However, FUTP was detected
in FU-treated LCMV-infected monolayers at the same
times post-infection (Fig. 5c). Interference was not
observed when LCMV was coinoculated with mock-
infected supernatant in the presence of FU (Fig. 5b; red
dashed line). FU has an effect on the infectivity of EMCV
and VSV (data available upon request), although the
interference experiment was negative for EMCV and VSV
(Fig. 5a).
Nucleic acids are much more sensitive to inactivation by
UV irradiation than proteins, through formation of cross-
links by UV in the 200–300 nm wavelength range. The
interference decreased 100-fold when the interfering
supernatants were irradiated with UV light (Fig. 5b; green
lines). As expected, neither DMEM with FCS nor the
neutralizing activity of mAb SD6 (specific for FMDV;
described in Mateu et al., 1987) was affected by the same
doses of UV irradiation. These results exclude proteins or
small molecules as the interfering component. The
interfering activity was not lost upon filtration through a
0.2 mm filter or by RNase A treatment (Fig. 5d). The
interfering activity manifested a dose effect, and it
increased slightly with the time allowed for LCMV to
replicate in the presence of FU (Fig. 6). RNA purified from
culture supernatants in which extinction was achieved did
not interfere (Fig. 5d). These results strongly suggest that
the interfering component was associated with LCMV
particles, as proposed in the lethal defection model.
Mutant spectrum complexity of LCMV in FU-
treated cultures
LCMV displays error-prone replication, and naturally
produces defective-interfering (DI) particles (Lazzarini et
al., 1981; Meyer & Southern, 1997; Popescu et al., 1976;
Sevilla et al., 2002; Welsh & Oldstone, 1977). To compare
the mutant spectrum complexity of LCMV in persistently
infected BHK-21 cells, grown in either the absence or
presence of FU, regions of the Z, L, GP and NP genes were
subjected to a clonal analysis. The populations passaged in
the presence of FU showed increased mutation frequency
compared with populations passaged in the absence of FU,
as expected (Grande-Pe´rez et al., 2002; Ojosnegros et al.,
2008). The only exception was at 48 h p.i. in populations
subjected to design 1, which had a mutation frequency
similar to the control populations and significantly lower
than the population at 48 h p.i. treated with FU under
design 2 (P,0.05) (Table 1). Possible reasons for this
difference were not investigated. A comparison of the
mutation types recorded in all mutant spectra analysed
(Table 2) indicated an abundance of UAC and AAG
transitions in virus from population subjected to FU
V. Martı´n and others
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Fig. 3. Detection of LCMV NP and LCMV particles in BHK-21 cells treated with interfering cell-culture supernatants. (a)
Detection of NP by immunofluorescence (panels 2, 5 and 8). Immunofluorescence of BHK-21 cells infected with LCMV at an
m.o.i. of 0.01 p.f.u. per cell at 24 h p.i. (panels 1, 2, 3), BHK-21 cells overlaid with culture supernatant of BHK-21 cells infected
with LCMV in the presence of FU, under conditions that eventually led to LCMV extinction (panels 4, 5, 6) (Fig. 1b, 96 h p.i.) and
BHK-21 cells overlaid with culture supernatant of BHK-21 cells infected with LCMV in the presence of FU, under conditions
that did not lead to LCMV extinction (panels 7, 8, 9) (Fig. 1a, 96 h p.i.). Panels 3, 6 and 9 show the corresponding samples with
nuclei labelled with DAPI, and panels 1, 4 and 7 show merged images. Original magnification was 63. (b) LCMV particles
(indicated by arrows) in sections of BHK-21 cells negatively stained with OsO4 and K3Fe(CN)6. Panel 1: BHK-21 cells infected
with LCMV at an m.o.i. of 1 p.f.u. per cell, at 24 h p.i. Panel 2: as panel 1, in the presence of 100 mg FU ml”1. Panel 3: BHK-21
cells overlaid with culture supernatant of BHK-21 cells infected with LCMV under conditions that led to LCMV extinction (Fig.
1b; 96 h p.i). Panel 4: BHK-21 cells overlaid with culture supernatant of BHK-21 cells infected with LCMV under conditions
such that LCMV was not extinct (Fig. 1a, 96 h p.i.).
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Fig. 4. Stochastic extinction of LCMV in BHK-21 cells and interference produced by FU-treated populations. (a) Monolayers of
3106 BHK-21 cells were infected with LCMV at an m.o.i. of 0.01 p.f.u. per cell in DMEM in the absence (”FU) or presence
(other bars) of 100 mg FU ml”1 (several dishes per time point). After the adsorption period, the monolayers were overlaid with
medium. At the indicated times post-infection, the supernatant of each plate was collected and assayed for infectivity in Vero
cell monolayers. Supernatants used in experiments detailed in (b) are labelled as 1* and 2*. (b–d) Replica monolayers of 3106
BHK-21 cells were infected with 0.01 p.f.u. per cell in the absence (LCMVA, LCMVB) or the presence of supernatants labelled
1* or 2* (b) or of the supernatants LCMV+FU96A, LCMV+FU96B (described in Fig. 1b) (c) or LCMV+FU102A,
LCMV+FU102B (described in Fig. 1a) (d). At the indicated times post-infection, 300 ml supernatant was collected and virus
infectivity was determined.
Fig. 5. Specificity of the interference exerted by culture medium from BHK-21 cells persistently infected with LCMV in the
presence of FU. (a) Duplicate monolayers of 3106 BHK-21 cells were infected with either EMCV, VSV or LCMV alone (Virus A,
virus B) or with EMCV, VSV or LCMV together with supernatant from BHK-21 cells persistently infected with LCMV in the
presence of FU (at 102 h p.i.; from the assay shown in Fig. 1b, which led to LCMV extinction) (Virus A+FU102, virus B+FU102).
Infections were carried out at an m.o.i. of 0.01 p.f.u. per cell. Samples were titrated in triplicate; standard deviations are given. (b)
Same as (a) in an infection with LCMV (blue lines) or either coinfected with the 102 h p.i. supernatant (Fig. 1a) (purple lines) or
irradiated with UV light (green lines) or coinfected with supernatant of a mock-infected BHK-21 cell culture in the presence of FU
(dashed red line). Samples were titrated in triplicate; standard deviations are given. (c) Confluent monolayers were extracted as
described in Airaksinen et al. (2003) and the NTPs were separated by HPLC (black arrows). A254 is expressed in mAU. Elution
profiles: 1, LCMV-infected BHK-21 cell extracts at 0 and 48 h p.i. in the absence of FU; 2, LCMV-infected BHK-21 cell extracts at
0 and 48 h p.i. in the presence of 100 mg FU ml”1; 3, BHK-21 cell extracts at 0 and 48 h p.i. coinfected with LCMV and medium
from infections from which the supernatant was removed and virus was not eliminated at 102 h p.i. (LCMV+FU102) in the
absence of FU. (d) Duplicate monolayers of 3106 BHK-21 cells were infected with either LCMV or LCMV together with RNase A
(LCMV+RNase A) or with supernatant from BHK-21 cells persistently infected with LCMV in the presence of FU (96 h p.i. from
assay Fig. 1b that led to LCMV extinction) (LCMV+FU96), or both (LCMV+FU96+RNase A) or this supernatant filtered through
a 0.2 mm filter (LCMV+FU96 filtered) or, finally, with viral RNA extracted from this supernatant (LCMV+RNA from FU96) as
indicated. The two groups of bars represent duplicate experiments. At 48 h p.i. samples were titrated in triplicate.
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mutagenesis, as expected (Agudo et al., 2008). For
unknown reasons, a relatively high frequency of GAU
and CAA transitions (27%) was observed in Z, but not in
other genes. This bias was not investigated further.
Examination of the presence of A, C, G or U at positions
21, 22, +1 and +2, relative to the site in which an AAG
mutation occurred, suggests that the FU-mediated increase
in mutation frequency was not due to ADAR-like activities
(Polson & Bass, 1994; Zahn et al., 2007) (Table 2).
In conclusion, extinction of LCMV that replicates in BHK-
21 cells in the presence of the mutagenic base analogue FU
can be avoided by renewing periodically the cell-culture
medium with fresh medium even while maintaining the
same FU concentration. FU-treated populations produce
an interfering activity that does not require the presence
of detectable infectivity and which is specific for LCMV,
UV radiation-sensitive and displays a dose- and time-
dependent behaviour. Production of the interfering activity
requires viral replication in the presence of FU. The results
suggest that the interfering activity is associated with
LCMV as a result of FU-mediated mutagenesis.
DISCUSSION
Negative-strand RNA viruses produce DI genomes, which
include point mutations and deletions, and particles that
can modulate replication of the corresponding standard
virus (Holland, 1990; Palma & Huang, 1974; Roux et al.,
1991). LCMV gene expression can be regulated by different
types of DI genomes (Meyer & Southern, 1997; Popescu et
al., 1976; Welsh & Buchmeier, 1979; Welsh et al., 1972;
Welsh & Oldstone, 1977; Welsh & Pfau, 1972). DI RNAs
can be viewed as one class of defective genomes, among
many types of mutants generated as a result of high
mutation rates during RNA genome replication, when
complementation by the corresponding standard virus is
allowed (Holland et al., 1982; Sevilla et al., 2002).
The lethal defection model of virus extinction (Grande-
Pe´rez et al., 2005b) emphasizes the role of a class of defective
genomes, termed defectors, in extinction. To substantiate
this model for LCMV, it was essential to demonstrate that
the interfering activity generated by the FU treatment was
superior to the interfering activity naturally associated with
stable LCMV replication. This point has been proven in the
present study by documenting FU-dependent generation of
interfering activity in sufficient levels so as to drive LCMV
towards extinction. No extinction was mediated by super-
natants of LCMV-infected cultures maintained in the
absence of FU. The interfering activity was specific for
LCMV and, therefore, could not be the result of any general
antiviral response or other FU-induced unspecific perturba-
tion of the cultured cells.
All evidence points to a subset of LCMV particles as the
component where the interfering activity resides, as
Fig. 6. Dose and time effects on interference.
(a) Monolayers of 3106 BHK-21 cells were
infected with 0.01 p.f.u. per cell or coinfected
with different amounts (250, 500 or 1000 ml)
of supernatant obtained at 96 h p.i. (see Fig.
1b) as indicated. At 48 h p.i., 300 ml super-
natant was collected and virus infectivity was
determined. (b) Monolayers of 3 106 BHK-21
cells were infected with LCMV at an m.o.i. of
0.01 p.f.u. LCMV per cell or coinfected with
supernatants obtained at different times post-
infection detailed on the horizontal axis. At 48 h
p.i., 300 ml supernatant was collected and
virus infectivity was determined. Standard
deviations are given. Open and filled bars
represent duplicate experiments.
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expected from prior studies on LCMV interference and as
proposed in the lethal defection model. In particular,
analysis of the LCMV genomes present in the interfering
populations suggests that FU mutagenesis was involved in
generating viral populations with a modest increase of
mutant spectrum complexity. The types and location of the
mutations indicate that ADAR 1-L or related activities were
not involved in the production of mutated LCMV genomes
(Polson & Bass, 1994; Zahn et al., 2007). The mutational
bias found, an abundance of AAG and UAC transitions,
coincides with that observed previously in FMDV and
LCMV populations treated with FU (Grande-Pe´rez et al.,
2002, 2005b; Pariente et al., 2001; Sierra et al., 2000).
Although the interfering activity was not dependent on the
infectivity present in the interfering populations, it was
dependent on the dose and age of the supernatant. It would
be interesting to test whether the FU-generated interfering
LCMV genomes can also exert an interference on other Old
World and New World arenaviruses. The results support
the lethal defection model of virus extinction and predict
that low mutagen doses, capable of increasing interference
levels, may be used in lethal mutagenesis protocols without
the need to reach high virus lethality as a result of
mutagenesis.
METHODS
Cells and virus. Growth of BHK-21 and Vero cells and virus
infections were carried out as described previously (Grande-Pe´rez et
al., 2002; Meyer et al., 2002; Sierra et al., 2000). LCMV ARM 53b is a
triple plaque-purified clone from LCMV ARM CA 1371, passaged
four times in BHK-21 cells. Rueckert EMCV strain and the Mudd–
Summers strain of VSV Indiana serotype were used in this study.
Virus infections. Semiconfluent monolayers of BHK-21 cells (about
2.86106 cells in 100 mm-diameter dishes) were infected with LCMV
ARM 53b at an m.o.i. of 0.01 p.f.u. per cell; the infected cultures were
maintained in 5 ml DMEM supplemented with 10% FCS, 2%
L-glutamine, 0.52% glucose and 50 mg gentamicin ml21, in either the
absence or the presence of FU (100 mg ml21), at 37 uC and 7% CO2.
Supernatants from infected cells (and from mock-infected cells) were
harvested at the times post-infection indicated in the corresponding
experiments, clarified by centrifugation at 2400 r.p.m. for 30 min at
4 uC and stored at 280 uC. Virus titres were determined on Vero cell
Table 1. Genetic complexity in the mutant spectra of LCMV replicated in BHK-21 cells, in the absence and presence of FU, at
different times post-infection
Viral RNA was sampled from the culture supernatant of BHK-21 cells persistently infected with LCMV, subjected to either experimental design 1 or
2, at the indicated times post-infection. The mutation frequency (substitutions per nucleotide) and Shannon entropy in the mutant spectra were
determined for the indicated genes, as detailed in Methods. Values showing a significant difference (P,0.05) between designs 1 and 2 in the
presence of FU are highlighted in bold. ND, Not determined.
FU Time (h p.i.) Design Mutation frequency
Z L GP NP
Absent 48 2 3.061024 2.061024 3.061024 7.561024
Absent 48 1 5.561024 5.061025 3.061024 3.761024
Absent 72 1 6.661024 3.461024 ND ND
Present 48 2 1.31023 3.41023 1.21023 3.11023
Present 48 1 8.61024 3.61024 1.81024 2.81024
Present 60 1 4.161023 2.561023 ND ND
Present 72 1 3.361023 2.361023 ND ND
Present 84 1 3.161023 ND ND ND
Present 88 1 2.261023 4.661023 ND ND
Present 96 1 3.361023 2.261023 ND ND
Present 102 1 1.161023 ND ND ND
FU Time (h p.i.) Design Shannon entropy
Z L GP NP
Absent 48 2 0.14 0.24 0.19 0.36
Absent 48 1 0.19 0.05 0.13 0.2
Absent 72 1 0.35 0.24 ND ND
Present 48 2 0.58 0.74 0.38 0.83
Present 48 1 0.61 0.22 0.12 0.41
Present 60 1 0.86 0.84 ND ND
Present 72 1 0.56 0.87 ND ND
Present 84 1 0.71 ND ND ND
Present 88 1 0.72 0.96 ND ND
Present 96 1 0.91 0.91 ND ND
Present 102 1 0.65 ND ND ND
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monolayers as follows: 16106 cells per well in six-well dishes were
infected by applying 100 ml of a dilution of the culture medium; after
90 min of adsorption at 37 uC, 7% CO2, the monolayer was washed
and overlaid with 4 ml DMEM supplemented with 0.7% FCS, 2% L-
glutamine, 50 mg gentamicin ml21 and 0.3% agar. After 7 days, cells
were stained with 2% crystal violet in 2% formaldehyde and plaques
were counted. The absence of plaques in supernatants from mock-
infected cultures confirmed the absence of viral contamination. Titres
are means of at least three independent titrations. Procedures for cell
culture and viral infections have been described previously (Domingo
et al., 1980; Sobrino et al., 1983).
Interference experiments. Semiconfluent monolayers of 2.86106
BHK-21 cells in 100 mm-diameter dishes were overlaid with a
mixture of LCMV ARM 53b (m.o.i. of 0.01 p.f.u. per cell) in 500 ml
DMEM and 500 ml of the supernatants to be tested for interfering
activity. Titrations were carried out as described above.
Viral inactivation. Virus-containing supernatants were irradiated
with 0.2 J cm22 using a UV 254 nm Energy Cross-linker CL-508
(UVItec Ltd). As a control, 10-fold dilutions of LCMV were treated in
the same manner, and no infectivity remained at any dilution (0 to
1027). As an additional control, DMEM supplemented with 10%
FCS, 2% L-glutamine, 0.52% glucose and 50 mg gentamicin ml21 was
irradiated under the same conditions, and no effect on the growth of
BHK-21 cells was observed. Also, the FMDV-specific mAb SD6 was
irradiated under the same conditions, without any effect on its FMDV
neutralization activity.
Drug treatment. Preparation of FU stock solutions, determination of
FU toxicity for BHK-21 cells and procedures for infections in the
presence of FU have been described previously (Grande-Pe´rez et al.,
2002; Ruiz-Jarabo et al., 2003). At least 80% cell survival was scored
after the FU treatments performed in the present study, in agreement
with previous determinations (Sierra et al., 2000). LCMV was
considered extinguished when no RT-PCR-amplifiable material and
no infectivity (limit of detection ¡33 p.f.u. ml21) could be observed
in the cell-culture supernatant after three blind passages of the
undiluted viral population in BHK-21 cells in standard culture
medium, in the absence of mutagens (Pariente et al., 2001; Sierra et
al., 2000). In addition, extinction was also ascertained in a cellular
extract of the BHK-21 cells after the first blind passage. Supernatants
used to interfere were preincubated with 10 mg RNase A ml21. A
sample of LCMV with DMEM was pretreated in the same way before
the infection.
RNA extraction, RT-PCR, nucleotide sequencing and molecular
cloning. Total RNA from the supernatant of cell cultures was
Table 2. Type of mutations found in LCMV and the position-dependent frequency context in mutations A to G of all the viral
supernatants of designs 1 and 2
Viral RNA was sampled from the culture supernatant of BHK-21 cells persistently infected with LCMV, subjected to either experimental design 1 or
2 as analysed in Table 1, in the absence (2FU) or presence (+FU) of FU in the culture medium. Details are given in Methods. In the upper part of
the table, changes of nucleotide found in the L, Z, GP and NP gene fragments sequenced are indicated. Numbers represent the total mutations
found for each nucleotide change. The most frequent changes found are highlighted in bold and underlined. In the lower part of the table, position-
dependent frequencies are given as percentages (per unit).
Mutation L Z GP NP
”FU +FU ”FU +FU ”FU +FU ”FU +FU
AAC 0 1 0 2 1 0 0 2
AAG 5 37 3 11 0 5 7 34
AAU 0 5 0 4 1 0 1 0
GAA 0 6 3 9 0 1 3 4
GAC 0 2 0 1 1 1 0 0
GAU 0 1 0 13 0 0 0 0
CAA 0 2 0 21 0 1 2 0
CAG 0 1 0 0 1 0 0 0
CAU 2 9 1 21 0 1 1 1
UAA 1 3 0 1 1 1 0 0
UAC 0 89 10 70 4 13 1 7
UAG 0 2 0 2 0 1 0 0
Transitions 7 141 17 111 3 20 12 46
Transversions 1 17 0 44 5 4 3 2
Total mutations 8 158 17 155 9 24 15 48
Nucleotides analysed 41 440 64 400 34 216 51 136 33 948 30 012 38 500 35 500
Nucleotide position Position-dependent frequency
A C G T
22 0.32 0.23 0.23 0.20
21 0.37 0.11 0.31 0.19
0 1 0 0 0
+1 0.32 0.08 0.15 0.43
+2 0.25 0.19 0.27 0.28
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extracted with Trizol (Invitrogen) following the manufacturer’s
protocol. RNAs were amplified by two-step RT-PCR using
ThermoScript reverse transcriptase (Invitrogen) and a reverse
(antisense) primer at 60 uC for 45 min, followed by PCR with Pfu
DNA polymerase (Promega). Molecular clones corresponding to the
Z gene (residues 7–402) and part of the L (residues 3662–4268), GP
(residues 247–759) and NP (residues 2223–2743) genes were obtained
by ligation of cDNA into the pGEM-T Easy vector (Promega) or into
the pCR 4Blunt-TOPO vector (Invitrogen) and transformation into
Escherichia coli DH5a cells. DNA from positive colonies was amplified
with a TempliPhi amplification kit (GE Healthcare) following the
manufacturer’s protocol and sequenced. Primer sequences are
available upon request. Clones obtained in pGEM-T Easy vector
were sequenced with T7 and SP6 promoter primers whereas pCR
4Blunt-TOPO clones were sequenced with T7 and M13R promoter
primers. Sequences were determined with at least twofold coverage.
Nucleotide positions are given in the viral (genomic) sense, and refer
to the consensus genomic sequence determined previously [Grande-
Pe´rez et al., 2005b; GenBank accession numbers AY847351 (L) and
AY847350 (S)]. To calculate the mutation frequency of mutant
spectra, repeated mutations were counted only once. Shannon
entropy was calculated with the formula Sn52Si[(pi6ln pi)/ln N],
in which pi is the frequency of each sequence in the clones analysed
and N is the total number of sequences compared (Volkenstein,
1994).
Quantification of the L genome segment. Total RNA from
samples was extracted with Trizol (Invitrogen). Reverse transcription
of the genomic segment L (viral RNA polymerase) was performed
with ThermoScript RT (Invitrogen) at 65 uC for 60 min with primer
L4268R (antisense). RNA corresponding to the L genomic segment
was quantified by two-step RT-PCR with the LightCycler Fast Start
DNA Master SYBR green I kit (Roche Applied Science). An LCMV
RNA fragment spanning nucleotides 3662–4268 (transcript from a
molecular DNA clone) was used as a standard.
Nucleotide pool analysis by HPLC. The procedure of Pogolotti &
Santi (1982) was used with minor modifications. Cell monolayers (in
100 mm-diameter dishes) were washed with PBS, treated with 600 ml
0.6 M trichloroacetic acid and incubated on ice for 10 min. The
supernatants were extracted with 1,1,2-trichlorotrifluoroethane
(Sigma) containing 0.5 M tri-n-octylamine (Sigma), vortexed for
10 s and centrifuged 30 s at 12 000 g. The entire treatment was
performed at 0–4 uC, using ice-cold solutions. Nucleotides were
separated using a 4.66250 mm Partisil 10 SAX column (Whatman)
with a 4.6630 mm Partisil 10 SAX precolumn (Phenomenex), using
buffers and elution conditions described by Airaksinen et al. (2003).
Chromatograms were analysed using the Unicorn 3.00 software
(Amersham Pharmacia Biotech). The values used to convert
mAU .ml for UTP, CTP, ATP, GTP and FUTP to pmol were 300.1,
492.1, 182.1, 191 and 323.4, respectively.
Immunofluorescence samples. Semiconfluent BHK-21 cell mono-
layers were infected with LCMV at an m.o.i. of 0.01 p.f.u. per cell or
with 1 ml of the sample to be tested. At 24 h p.i., the monolayers were
washed and fixed in methanol/acetone at 220 uC. Samples were
blocked in PBS, 1% BSA for 15 min and incubated with anti-LCMV
NP antibody 113 (Buchmeier et al., 1981; Weber & Buchmeier, 1988),
diluted 1 : 100 in blocking solution, for 1 h at room temperature.
After three washes in PBS, samples were incubated with donkey anti-
mouse Alexa-488 secondary antibody (Invitrogen), diluted 1 : 500 in
blocking solution, for 45 min at room temperature. Cell nuclei were
counterstained using DAPI (Invitrogen) following the manufacturer’s
instructions. Finally, samples were washed three times with PBS and
once with distilled water and rinsed with absolute ethanol before
mounting with Prolong (Invitrogen). An inverted Axiovert 200 Zeiss
fluorescence microscope with a CCD-monochrome colour camera
was used to visualize the samples.
Electron microscopy. BHK-21 cell monolayers were infected with
LCMV at an m.o.i. of 1 p.f.u. per cell in the presence or absence of
FU, or with 1 ml of the supernatants without detectable infectivity in
Vero cells. At 24 or 96 h p.i., cells were fixed for 90 min at room
temperature with 4% paraformaldehyde and 2% glutaraldehyde in
sodium phosphate buffer (0.1 M pH 7.4) and then post-fixed for 1 h
at 4 uC with 1% OsO4 and 1.5% K3Fe(CN)6 in H2O. After extensive
washing, cells were dehydrated in increasing concentrations of
ethanol and embedded in Epon 812 resin. Ultrathin sections were
examined and photographed on a JEOL 1010 transmission electron
microscope operating at 80 kV.
Bioinformatic analysis of the molecular clones. Mutation
detection was obtained by comparison of each sequence with the
consensus sequence, after multiple sequence alignment (MSA), using
the MUSCLE program (Edgar, 2004).
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